Jean-Pierre Malhaire

Prediction of outcome using pretreatment 18F-FDG PET/CT and MRI radiomics in locally advanced cervical cancer treated with chemoradiotherapy

François Lucia, Dimitris Visvikis, Marie-Charlotte Desseroit et al. · European Journal of Nuclear Medicine and Molecular Imaging · 2017 · 248 citations · Full text

Medicine, Nuclear Medicine, Oncology +16

Personalised chemotherapy based on tumour marker decline in poor prognosis germ-cell tumours (GETUG 13): a phase 3, multicentre, randomised trial

Karim Fizazi, Lance C. Pagliaro, Agnès Laplanche et al. · The Lancet Oncology · 2014 · 200 citations · Full text

Medicine, Oncology, Chemotherapy +12

Tamoxifen Adjuvant Treatment Duration in Early Breast Cancer: Initial Results of a Randomized Study Comparing Short-Term Treatment With Long-Term Treatment

T. Delozier, M. Spielmann, Josette Macé-Lesec’h et al. · Journal of Clinical Oncology · 2000 · 51 citations

Medicine, Oncology, Breast Oncology +11

A Risk-adapted Study of Cisplatin and Etoposide, with or Without Ifosfamide, in Patients with Metastatic Seminoma: Results of the GETUG S99 Multicenter Prospective Study

Karim Fizazi, R. Delva, Armelle Caty et al. · European Urology · 2013 · 51 citations

Medicine, Oncology, Pharmacology +12

Impact of the per-operatory application of GLIADEL wafers (BCNU, carmustine) in combination with temozolomide and radiotherapy in patients with glioblastoma multiforme: Efficacy and toxicity

P. Miglierini, Mohamed Bouchekoua, Benoı̂t Rousseau et al. · Clinical Neurology and Neurosurgery · 2012 · 48 citations

Medicine, Oncology, Radiation Oncology +16